Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 30 May 2014 for OSIRIS THERAPEUTICS, INC., €2,374.
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
No signal scores available.
Matthew Paul Neumayer: trading record in brief
All filings by Matthew Paul Neumayer on record concern Osiris Therapeutics, Inc. The record holds 18 filings, for trades running from 20 August 2013 to 29 May 2014.
Every open-market trade on record is a sale: 4 sales worth €262k. Other entries cover 14 option exercises. So far in 2014, the count stands at no purchases and 3 sales.
The record was last updated on 30 May 2014 with an option exercise (€3,260) in Osiris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew Paul Neumayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
500 shares@ US$6.46Common StockSEC:0001179110-14-009419:0
500 shares@ US$15.55Common STockSEC:0001179110-14-009419:1
1,000 shares@ US$7.13Common StockSEC:0001179110-14-009316:0
1,000 shares@ US$7.74Common StockSEC:0001179110-14-009316:1
875 shares@ US$5.08Common StockSEC:0001179110-14-009316:2
875 shares@ US$7.73Common STockSEC:0001179110-14-009316:3
3,750 shares@ US$16.10Common StockSEC:0001179110-14-009316:4
2,000 shares@ US$7.13Common StockSEC:0001179110-13-013312:0
1,500 shares@ US$6.46Common StockSEC:0001179110-13-013312:1
3,000 shares@ US$7.74Common StockSEC:0001179110-13-013312:2
4,000 shares@ US$16.75Common StockSEC:0001179110-13-013312:3
875 shares@ US$5.08Common StockSEC:0001179110-13-013312:4
11,375 shares@ US$19.75Common STockSEC:0001179110-13-013312:5
13 of 13 declarations
